Skip to content
Clinical Trials – home

Diabetic gastroparesis Diagnostics

0 / 2 trials open to patients8 countries

In short

Diagnosing diabetic gastroparesis requires careful evaluation to confirm delayed stomach emptying and rule out other conditions that might cause similar symptoms. Understanding when to seek testing and what to expect during the diagnostic process can help patients take the first steps toward managing this challenging complication of diabetes.

Key points

  • Gastroparesis often develops in people who have had diabetes for at least 10 years, especially when blood sugar control has been poor over time
  • The gastric emptying scintigraphy test is the gold standard for diagnosis, using a small amount of safe radioactive material in food to track stomach emptying over four hours
  • Endoscopy cannot diagnose gastroparesis but is crucial for ruling out blockages, ulcers, and other conditions that cause similar symptoms
  • Some people with gastroparesis digest liquids normally but struggle with solid foods, which is why specialized solid meal tests may be more accurate than liquid tests
  • Clinical trials for gastroparesis treatments require specific diagnostic criteria including documented delayed gastric emptying and symptom severity scores
  • Research shows that while gastroparesis significantly affects quality of life, it does not appear to increase mortality rates when other health conditions are properly managed
  • Once gastroparesis symptoms begin, they typically persist and remain stable over 12 to 25 years, even with improved blood sugar control
  • Certain medications can mimic gastroparesis symptoms by slowing stomach emptying, so a complete medication review is essential during diagnosis

Introduction: When to Seek Diagnostic Testing

If you have diabetes and begin experiencing persistent digestive problems, it may be time to talk with your doctor about testing for gastroparesis. This condition, where the stomach empties food more slowly than normal, often develops in people who have lived with diabetes for at least 10 years, particularly when blood sugar levels have been poorly controlled over time.

You should consider seeking diagnostic evaluation if you notice symptoms that interfere with your daily life or make it difficult to control your blood sugar. These warning signs include feeling uncomfortably full after eating just a few bites of food, experiencing frequent nausea or vomiting, having persistent bloating or belly pain, or noticing that your blood sugar levels swing unpredictably even when you follow your usual diabetes management plan.

The timing of these symptoms matters, too. With gastroparesis, you might feel stuffed immediately after starting to eat, or the sensation of fullness might persist for hours after a meal ends. Some people find themselves vomiting food that looks undigested, even many hours after eating. These aren't occasional inconveniences—they represent patterns that happen regularly and significantly affect your ability to eat normally and maintain proper nutrition.

It's especially important to seek medical attention if your symptoms become severe. This includes vomiting that happens daily, inability to keep down food or liquids for extended periods, unexpected weight loss, or difficulty taking your diabetes medications because of stomach problems. These situations require prompt evaluation because they can quickly lead to dangerous complications that affect your overall health.

Classic Diagnostic Methods for Identifying Gastroparesis

When you visit your doctor with symptoms suggesting gastroparesis, the diagnostic process typically begins with a thorough discussion of your medical history and a physical examination. Your doctor will ask detailed questions about your symptoms—when they occur, how long they last, what foods seem to trigger them, and how they affect your daily activities. Because you have diabetes, your doctor will also want to understand how well your blood sugar has been controlled over the years and whether you've developed other diabetes-related complications.

The physical exam itself provides important clues. Your doctor will check for signs of malnutrition or dehydration, examine your abdomen for tenderness or bloating, and may listen for sounds that indicate how your digestive system is functioning. They'll also review your current medications, since certain drugs—including some pain relievers, antidepressants, and medications for high blood pressure—can slow stomach emptying and create symptoms similar to gastroparesis.

Gastric Emptying Tests

The most reliable way to diagnose gastroparesis involves measuring how quickly your stomach empties after you eat. This is done through specialized tests that track food movement through your digestive system. The gold standard test is called scintigraphy, also known as a gastric emptying study or gastric emptying scan.

During a scintigraphy test, you'll eat a light meal—typically something like eggs and toast—that contains a small amount of radioactive material. This material is completely safe and allows a special scanner to follow the food's path through your digestive system. You'll lie under the scanner, which takes images of your stomach at regular intervals, usually every hour for up to four hours. If the scan shows that more than half of your meal remains in your stomach after 90 minutes, or more than 10 percent remains after four hours, this indicates gastroparesis.

An alternative approach involves breath tests. For these tests, you consume food or liquid containing a special substance that your body absorbs and eventually releases through your breath. Your healthcare team collects breath samples over several hours to measure the amount of this substance present. The timing and quantity detected in your breath reveals how fast your stomach empties. While breath tests are less commonly used than scintigraphy, they offer a non-invasive option for assessing stomach function.

Imaging Studies

Sometimes doctors use imaging tests to look for mechanical blockages or other structural problems that might explain your symptoms. A barium X-ray, also called an upper gastrointestinal series or barium swallow, involves drinking a thick liquid containing barium that coats the inside of your digestive tract. The barium shows up clearly on X-rays, allowing your doctor to see the shape and function of your esophagus, stomach, and upper small intestine. Before this test, you'll need to fast for 12 hours. In gastroparesis, the X-ray might reveal food remaining in the stomach despite the fasting period.

A variation called the barium beefsteak meal involves eating solid food mixed with barium rather than just drinking liquid barium. This test can be particularly useful for people with diabetes because many digest liquids normally even when solid food empties slowly. The radiologist watches on X-ray as you digest the barium-containing meal, which provides a more accurate picture of how your stomach handles typical foods.

Ultrasound uses high-frequency sound waves to create images of your internal organs. While not typically the primary test for diagnosing gastroparesis, ultrasound can help your doctor check whether problems with your gallbladder or kidneys might be causing your symptoms. This painless test involves moving a device called a transducer across your abdomen while you lie on an examination table.

Endoscopic Procedures

Your doctor may recommend an upper gastrointestinal endoscopy, also called esophagogastroduodenoscopy or EGD. This procedure uses a thin, flexible tube with a tiny camera on the end to directly view the inside of your esophagus, stomach, and the beginning of your small intestine. The endoscope is gently passed through your mouth and down into your digestive tract while you're sedated to keep you comfortable.

Although endoscopy cannot diagnose gastroparesis itself, it serves an important purpose. The visual examination helps rule out other conditions that cause similar symptoms, such as ulcers, inflammation, or physical blockages at the stomach outlet—a condition called pyloric stenosis where the opening between the stomach and small intestine becomes narrowed. Finding and treating these other conditions is crucial because their management differs significantly from gastroparesis treatment.

Blood Sugar Monitoring

Because gastroparesis and diabetes are so closely connected, your doctor will carefully check your blood sugar levels as part of the diagnostic process. High blood sugar itself can slow stomach emptying, so it's important to understand whether poor diabetes control is contributing to your symptoms. You may need to check your blood sugar more frequently and keep detailed records of the results, especially noting levels after meals.

In some cases, acute spikes in blood sugar can temporarily delay gastric emptying, and these effects might improve when blood sugar returns to normal. However, chronic high blood sugar over many years can cause permanent nerve damage that leads to persistent gastroparesis, even when blood sugar control improves later. Understanding this distinction helps guide treatment decisions.

Diagnostic Criteria for Clinical Trial Enrollment

When researchers study new treatments for diabetic gastroparesis through clinical trials, they use specific diagnostic criteria to determine which patients can participate. These standards ensure that all participants truly have gastroparesis and that study results can be accurately interpreted. Understanding these criteria can help you know whether you might qualify for research studies exploring new treatment options.

Clinical trials typically require objective evidence of delayed gastric emptying through standardized testing. The gastric emptying scintigraphy test serves as the cornerstone for trial enrollment. Most studies define gastroparesis as retention of more than 10 percent of a standardized meal in the stomach at four hours after eating, though some trials may use slightly different cutoff values or measure emptying at additional time points.

Beyond confirming delayed emptying, clinical trials usually require documented symptoms consistent with gastroparesis. Researchers often ask potential participants to rate the severity of symptoms like nausea, vomiting, early fullness, bloating, and abdominal pain using standardized questionnaires. These symptom scores help researchers match participants to appropriate studies and measure whether treatments improve quality of life, not just test results.

For trials specifically studying diabetic gastroparesis, you'll need confirmation of your diabetes diagnosis and often documentation of how long you've had diabetes and how well it has been controlled. Some studies accept both type 1 and type 2 diabetes, while others focus on just one type. Researchers may require recent measurements of your hemoglobin A1C—a blood test that shows your average blood sugar control over the past two to three months—to understand the relationship between diabetes management and gastroparesis severity.

Clinical trials also look for evidence that other diabetes complications may already be present, since gastroparesis often develops alongside damage to other organ systems. This might include checking for signs of nerve damage in your feet (peripheral neuropathy), kidney problems, or eye disease. These assessments help researchers understand the broader impact of diabetes on your health and ensure that study treatments are safe for your particular situation.

Importantly, trials typically require ruling out other causes of delayed gastric emptying. Endoscopy results showing no mechanical obstruction become part of your eligibility assessment. Researchers need to verify that your symptoms stem from gastroparesis related to diabetes, not from other conditions that might respond differently to treatment. This might involve reviewing results from recent imaging studies or requiring new endoscopy if previous tests are outdated.

Some clinical trials establish minimum symptom duration requirements, such as experiencing gastroparesis symptoms for at least six months or a year. This helps ensure that participants have chronic gastroparesis rather than temporary stomach problems that might resolve on their own. Researchers want to study people whose condition persists and significantly impacts their daily life over time.

Blood tests form another standard component of clinical trial screening. Beyond blood sugar measurements, researchers typically check your kidney function, liver function, blood counts, and electrolyte levels. These tests ensure your overall health is stable enough to safely participate in the study and help researchers identify any other medical issues that might affect how you respond to experimental treatments.

Many trials exclude people taking certain medications that could interfere with study results or pose safety risks when combined with experimental treatments. You may need to discuss your complete medication list with the research team to determine eligibility. In some cases, you might be able to stop problematic medications temporarily to participate, but this decision always requires careful medical supervision.

Prognosis and Survival Rate

Prognosis

The outlook for people with diabetic gastroparesis varies considerably depending on several factors. Once gastroparesis symptoms begin, they typically persist and remain relatively stable over 12 to 25 years, even when blood sugar control improves. This means that the nerve and muscle damage causing the condition often becomes permanent, and the goal of treatment shifts to managing symptoms rather than curing the disease.

However, the progression of diabetic gastroparesis is generally predictable rather than rapidly deteriorating. Many people learn to manage their condition through careful attention to diet, medications, and blood sugar control, allowing them to maintain a reasonable quality of life. The severity of symptoms can fluctuate, with some days or periods being better than others, which is considered a normal pattern with this condition.

Controlling diabetes remains one of the most important factors affecting prognosis. When people achieve better blood sugar control, their risk of developing additional complications throughout the body decreases significantly. While existing gastroparesis may not reverse, preventing further nerve damage can help stabilize symptoms and reduce the risk of other serious diabetes complications.

The development of complications from gastroparesis itself can affect the outlook. Severe dehydration from persistent vomiting, malnutrition from inability to eat adequately, formation of bezoars (solid masses of undigested food), and unpredictable blood sugar swings all present challenges that require ongoing medical attention. People who experience these complications may need more intensive treatment, including hospitalization, nutritional support, or advanced therapeutic interventions.

Survival Rate

Research indicates that diabetic gastroparesis itself does not appear to increase mortality rates when adjusted for other health conditions. In a study following 86 patients with diabetes who had gastroparesis for at least nine years, researchers found that gastroparesis was not associated with increased mortality after adjustments were made for other disorders. This suggests that people with diabetic gastroparesis have a normal life expectancy when their other health conditions are appropriately managed.

Another study published by Chang and colleagues, which followed patients over a 25-year period, found no association between delayed gastric emptying and increased mortality. While gastroparesis substantially impairs quality of life and creates significant daily challenges, current evidence does not suggest that it directly shortens lifespan.

It's important to understand that while gastroparesis itself may not be life-threatening, the overall health status of people with diabetes matters greatly. Those who develop gastroparesis typically have had poorly controlled diabetes for many years and often have multiple complications affecting various organs. Managing these other conditions—including heart disease, kidney disease, and nerve damage—becomes crucial for long-term survival and well-being.

Did you know?

  1. Gastroparesis affects women almost twice as often as men, with approximately 68.5 percent of diagnosed cases occurring in women compared to 31.4 percent in men, though researchers don't fully understand why this gender difference exists.[15]
  2. The radioactive material used in gastric emptying scintigraphy tests is so minimal that it's completely safe—you could undergo this test and then safely hold a baby or be around pregnant women immediately afterward without any risk.[9]
  3. Some people with diabetic gastroparesis can digest liquids normally even when solid foods move extremely slowly through their stomach, which is why doctors sometimes use a solid barium meal rather than just liquid barium for more accurate testing.[8]

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Diabetic gastroparesis

Recruiting trials first

See all 2 trials →
Quick filters

2 clinical trials in this condition

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Tradipitant
  • Sponsor:Vanda Pharmaceuticals Inc.
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Naronapride Dihydrochloride Trihydrate
  • Sponsor:Dr. Falk Pharma GmbH
See all 2 trials →filters applied: condition = Diabetic gastroparesis

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).